Darzalex® (daratumumab) – Expanded indication
September 26, 2019 - Janssen announced the FDA approval of Darzalex (daratumumab), in combination with Velcade® (bortezomib), Thalomid® (thalidomide), and dexamethasone, for the treatment of multiple myeloma in newly diagnosed patients who are eligible for autologous stem cell transplant (ASCT).
Top